Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Change in Account Payables (2020 - 2025)

Ovid Therapeutics' Change in Account Payables history spans 6 years, with the latest figure at $246000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 48.86% year-over-year to $246000.0; the TTM value through Dec 2025 reached -$1.2 million, down 141.02%, while the annual FY2025 figure was -$1.2 million, 141.02% down from the prior year.
  • Change in Account Payables reached $246000.0 in Q4 2025 per OVID's latest filing, up from -$2.2 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $4.0 million in Q4 2021 to a low of -$4.9 million in Q1 2022.
  • Average Change in Account Payables over 5 years is -$182507.3, with a median of $148713.0 recorded in 2021.
  • Peak YoY movement for Change in Account Payables: crashed 2509.66% in 2022, then skyrocketed 170.26% in 2023.
  • A 5-year view of Change in Account Payables shows it stood at $4.0 million in 2021, then crashed by 76.92% to $919844.0 in 2022, then surged by 170.26% to $2.5 million in 2023, then crashed by 80.65% to $481000.0 in 2024, then plummeted by 48.86% to $246000.0 in 2025.
  • Per Business Quant, the three most recent readings for OVID's Change in Account Payables are $246000.0 (Q4 2025), -$2.2 million (Q3 2025), and $2.0 million (Q2 2025).